Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 6, 1998

View Archived Issues

M-5011, a novel NSAID, shown to inhibit vertebral bone loss in arthritic rats

SmithKline Beecham to market smoking cessation patch in China

SB acquires stake in Romanian pharmaceutical market

Inex to focus internal R&D program on three cancer drug product candidates

Aurora Biosciences completes first stage of UHTSS for Warner-Lambert

Canadian research team uncovers genetic basis of epileptic disorder

Antitumor agents with high potency and selectivity under evaluation at Shionogi

Banyu patents new series of NPY antagonists for obesity, bulimia, diabetes

Tanabe presents new antidiabetic agents

Basic research in the field of vitronectin antagonists revealed by HMR

Glycylcycline antibiotic enters clinical testing

Ono discloses compounds with high binding affinity for prostanoid EP4 receptors

Dopamine reuptake inhibitors synthesized at Pola, useful for Parkinson's disease

HMR-3647: the first ketolide to reach advanced-stage clinical testing

Preclinical profile of BI-397, a promising new glycopeptide antibiotic

MiKasome phase I data presented at ICAAC; development update

Lilly glycopeptide advances to phase II for various resistant infections

Novel acid-stable macrolides from Abbott presented at ICAAC

Abbott obtains new ketolides with improved activity against MLS-resistant strains

New lead anti-HIV compound discovered by Italian university researchers

The PAF antagonist MFH-1 shows potential as an adjunct in the therapy of AIDS

Potent, orally absorbed HIV-1 protease inhibitors selected from series of azadipeptides

New broad-spectrum anti-MRSA pyrrolidinone cephalosporin and water-soluble prodrug from Roche

La Jolla enrolls patients in phase II/III trial for lupus treatment

Osiris begins clinical trials with hMSC product in cancer patients

Lidak proposes name change to Avanir

Centocor exercises option for license to HuMAb-Mouse technology

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...